EMEA-000713-PIP02-10-M05

Key facts

Invented name
Pixuvri
Active substance
pixantrone (dimaleate)
Therapeutic area
Oncology
Decision number
P/0227/2018
PIP number
EMEA-000713-PIP02-10-M05
Pharmaceutical form(s)
Powder for concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of non-Hodgkin lymphoma
Route(s) of administration
Intravenous use
Contact for public enquiries
CTI Life Sciences Limited

Tel. +1 2062724260
E-mail: bseeley@ctibiopharma.com

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating